Pharma Stocks

Novavax, Inc (NASDAQ: NVAX) shares closed 12.24% higher in the regular session on Monday. What Happened: The biotechnology company working on a COVID-19 vaccine saw its shares move 0.74% higher in the after-hours trading. The New York State Common Retirement Fund, the third-largest public pension...

Moderna Inc (NASDAQ: MRNA), a company founded in 2010, is now worth more than the 130-year old Merck & Co., Inc (NYSE: MRK) in terms of market capitalization. What Happened: Moderna’s shares spiked Monday amid a string of positive news including being granted provisional registration...

CVS (NYSE: CVS), Walgreens (NASDAQ: WBA) and Rite Aid (NYSE: RAD) shares lost ground Wednesday after a Business Insider report that Amazon (NASDAQ: AMZN) is considering entering the physical pharmacy retail space. The story's three unnamed sources, who were not authorized to...

Stockholm headquartered private equity group EQT AB will buy Swedish pharma company Recipharm AB for $2.1 billion, according to company's press release. The transaction will be routed through Roar BidCo AB, a limited liability company established on Nov. 10,...

Pfizer Inc. (NYSE: PFE) is seeking emergency approval for its COVID-19 vaccine in India, according to media sources in the country. What Happened: The vaccine developed together with BioNTech SE - ADR (NASDAQ: BNTX) was approved in the U.K. last week. The pharmaceutical...

The U.K. has secured two million more doses of COVID-19 vaccine from Moderna Inc (NASDAQ: MRNA) and is expected to approve the vaccine made by Pfizer Inc (NYSE: PFE) and BioNTech SE - ADR (NASDAQ: BNTX) this week. What Happened: Moderna is to provide...

Biotech stocks had a rather uneventful week, as the sector was seen mostly flatlining amid light trading volume ahead of the Thanksgiving holiday. The week kickstarted with lukewarm news on the coronavirus vaccine front, as AstraZeneca plc (NASDAQ: AZN) reported late-stage interim efficacy data...

Pfizer Inc. (NYSE: PFE) has disclosed in its earnings report that it received an official request for information from the US Securities and Exchange Commission, according to The Wall Street Journal. What Happened: The pharmaceutical company received formal requests regarding its...

New York Governor Andrew Cuomo on Thursday announced the state has filed civil charges against Johnson & Johnson (NYSE: JNJ), accusing it of insurance fraud in connection with understating the risks posed by opioid drugs to doctors and elderly patients.  What Happened: The...

Bayer AG (OTC: BAYRY) will pay between $10.1 to $10.9 billion to resolve litigation over the weedkiller Roundup.  What Happened Bayer inherited the litigation after it acquired Monsanto Co in 2018, the original maker of the herbicide Roundup.  The resolution will allow Bayer to settle...

Johnson & Johnson (NYSE: JNJ) will begin the human clinical trials of its novel coronavirus (COVID-19) vaccine in July, the company announced Wednesday. What Happened The human trials of the Johnson & Johnson COVID-19 vaccine were earlier expected to begin in September. The pharmaceutical...

Novavax Inc. (NASDAQ: NVAX) announced on Monday it had started the first phase of its novel coronavirus (COVID-19) vaccine trials. What Happened The pharmaceutical company said it had enrolled the first participants for the testing of the "NVX‑CoV2373" vaccine, and the...

Teladoc Health Inc. (NYSE: TDOC) on Wednesday reported that it reduced losses in the first quarter compared to a year ago, as the novel coronavirus (COVID-19) pandemic caused a surge in demand for its services. Q1 Earnings The New York-based company posted a net loss of $29.6 million in Q1, down...

Pharmaceutical giant Novartis AG's (NYSE: NVS) subsidiary Sandoz Inc. has agreed to pay $195 million in penalties to avoid facing criminal charges in a price-fixing case, the Justice Department announced Monday. What Happened The New Jersey-based pharmaceutical company was charged with...

It appears more and more likely a case against opioid manufacturers and distributors will proceed to trial in New York state, keeping Bank of America bearish on the companies despite recent performance. The recent denial of a motion to delay the case — which the state brought against the...